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Introduction
While considerable progress has been made towards the
Millennium Development Goals (MDGs) and childhood diarrheal
diseases have reduced from 4.6 million to 0.8 million over the last
three decades, the number of diarrhoeal deaths remains
unacceptably high [1–8]. These deaths remain concentrated in a
relatively small number of countries and in poor and difficult-to-
reach populations. For diarrhoeal disease in particular, coverage
indicators for key preventive and curative interventions remain
suboptimal, suggesting that efforts to reduce diarrhoea-related
child deaths by two-thirds have stalled [4,5,9–14]. Moreover,
although deaths have declined globally, the proportion of decline
has been greater in high-income countries, suggesting that
significant inequities between the developed and developing
countries have persisted [6].
As major growth and brain development occur in the first two
years of life, the impact of diarrhoeal morbidity on disability-
adjusted life years (DALYs) is likely to remain substantial even as
diarrhoeal mortality diminishes following current trends [15–17].
Nutritional deficits caused by diarrhoea can affect a child’s growth,
fitness, cognition, and performance at school [15,17]. It is
estimated that each diarrhoeal episode experienced by a child in
the months preceding the child’s second birthday increases the risk
of being stunted by 5% [18]. Moreover, diarrhoeal illness in early
childhood is associated with long-term adverse cognitive effects
and decreased work productivity later in life [15].
Trends in coverage of many life-saving interventions have
varied [9,10]. Santosham et al. [12] reported that from 1982 to
1988 the proportion of children under age 5 receiving oral
rehydration solution (ORS) grew from 5% to 60% as a result of
substantial investment in diarrhoeal control programs. During this
time, Brazil and Egypt made enormous progress in reducing
childhood mortality due to diarrhoea [12,19], reporting a 67%
and 74% reduction, respectively. Regrettably, the median
coverage of ORS has dropped since the late 1980s. Currently,
the median percentage of access to ORS is 30.9% [13,14]. The
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previous Countdown Report, published in 2008, combined data
for ORS and ORS with continued feeding, reporting a median
coverage of 38% with a range of 7%–76% [9]. Thus, coverage
indicators for diarrhoea treatment have not progressed over the
past four years.
Mismatch of Burden and Investments in Programs
and Research
Investment into diarrhoeal disease control has been dispropor-
tionately low in comparison to other diseases, and coverage has
stalled [4,12,20]. Only about 2 cents for every 10 US dollars in
health research annually is allocated to pneumonia and diarrhoea
[21]. While diarrhoeal disease control programs receive US $10
per DALY globally, diabetes and cardiovascular disease pro-
grammes receive US $102.07 per DALY and US $63.45 per
DALY, respectively [4,20]. A recognized limitation of research
investments in the area relate to lack of consensus on priorities.
The 2009 Global Forum Report on financial flows in health
research highlights the importance of researchers and policy
makers ensuring economic and social returns on research. It
emphasizes transparency in investments and attention to health
inequities [22]. The Child Health and Nutrition Research
Initiative (CHNRI) developed a method to systematically and
transparently identify research gaps and resource priorities
[4,7,23–27]. Two previous exercises have employed the CHNRI
method to identify research priorities to reduce mortality from
childhood diarrhoea by 2015, but these previous CHNRI exercises
had several limitations [4,23]. Firstly, the main focus was on
mortality and disease burden within the time frame of the MDGs,
i.e. 2015, which influenced the choice of interventions and
research options. The exercises were also limited to 10 [23] and 13
[4] participants, and 46 and 154 scored research priorities,
respectively. Given the need to focus on achieving major reduction
in diarrheal deaths and morbidity over a longer time frame to
make it consistent with the Global Action Plan for Pneumonia and
Diarrhoea (GAPPD) [28], we undertook a fresh exercise building
and expanding the previous two exercises in terms of the
timeframe for the research options, number of research options
generated, and number of participants. We employed the CHNRI
method to identify research gaps and resource priorities to reduce
morbidity and mortality caused by childhood diarrhoeal disease over
the next 15 years.
Methods
The CHNRI methodology was created to assist those who
develop research policy and/or invest in health research by
identifying research gaps and resource priorities systematically and
transparently in a specified context [26,27,29]. The aim is to help
policy makers understand the potential risks and benefits of a
range of research options. This methodology has been used
previously to identify research gaps and resource priorities in areas
such as birth asphyxia and childhood pneumonia [24,25].
The CHNRI method has four stages: (i) the context of the
problem and the criteria for priority setting are defined; (ii)
technical experts generate and rank research questions; (iii)
stakeholders give input regarding the weighting of the CHNRI
criteria; and, (iv) research scores for the research questions are
calculated and agreement between experts is analysed [25].
Detailed information on the CHNRI methodology has been
provided in previous publications [24,25]. We supplemented the
CHNRI method by hosting an international workshop on the
identified research priorities, which is reported elsewhere [30].
(i) Context of the Problem Is Defined
In consideration of the substantial mortality rates of diarrhoea
and its effect on morbidity as described above, we used the
CHNRI method to identify research gaps and address resource
priorities to questions related to both mortality and morbidity
caused by childhood diarrhoeal disease. Our exercise specifically
targeted a time trajectory over the next 15 years to be broadly
consistent with the emerging targets for eliminating diarrhoea and
pneumonia deaths by 2035 [31].
(ii) Technical Experts Provide Input
Ten areas of focus, defined by the results of the previous
CHNRI exercises [4,23], were identified and experts in each area
were invited to be team leaders (Figure 1). Researchers identified
team leaders by their scientific and subject expertise, contributions,
and willingness to lead respective work groups. Each team leader
was instructed to assemble a diverse virtual team of approximately
20 global experts representing different genders, age groups, and
geographical locations. We also aimed to have representation of
high-, middle- and low-income countries. Global experts were not
permitted to participate in more than two teams. Information on
the composition of each of the ten teams, including team leaders,
global experts, countries represented, and institutional affiliations,
is available in Table S16 of Supporting Information S1.
The global experts were asked to generate distinct, answerable
research questions to be priorities over the next 15 years in their
corresponding teams, covering the broad research domains of:
N Description (epidemiology)
N Discovery (new interventions)
N Development (improving existing interventions)
N Delivery (health policy systems, including cost-effectiveness)
These four domains (also termed D4), intended to be universally
applicable to all health research, were proposed by the Council on
Summary Points
N This paper aims to identify research priorities, using the
Child Health and Nutrition Research Initiative’s (CHNRI’s)
method, for global childhood diarrhoeal disease over the
next 15 years.
N Ten teams were established, and over 150 experts
participated on one or more teams, generating and
scoring 466 research questions.
N Research questions involving improving implementa-
tion, especially through behaviour change and other
delivery strategies ranked highly; oral rehydration and
zinc were also seen as priorities, as research questions
asking to identify driving factors of caregiver demand for
oral rehydration solution (ORS) and zinc and develop-
ment of an ORS formulation that reduces stool output
were ranked highly.
N Despite a range of discovery-related research topics,
implementation research questions related to known
interventions for childhood diarrhoeal diseases were
ranked highly by most experts.
N In tandem with the Global Action Plan for Pneumonia
and Diarrhoea, concerted efforts by a range of stake-
holders in implementation research will be needed to
equitably scale up already proven, effective interven-
tions.
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Health Research and Development and modified by Rudan et al.
[29]. Sample ‘‘seed questions’’ were provided to each team; these
questions were taken from a previous CHNRI exercise to identify
research priorities in childhood diarrhoea mortality [4].
Team leaders collected research questions submitted by their
experts, eliminated redundancies, and chose the top questions to
be scored. Research questions were scored using five criteria: (a)
answerability; (b) likelihood of effectiveness; (c) likelihood of
deliverability; (d) disease burden reduction; and, (e) effect on
equity. A detailed description of the criteria can be found in Table
S17 of Supporting Information S1. Experts were asked to score the
questions, giving a 1 for yes, 0 for no, and 0.5 if they were
undecided. Experts were asked to leave cells blank if they did not
feel knowledgeable enough to answer the question. Blank cells did
not affect the questions’ scores. The Monitoring and Evaluation
team recognized at an early stage that the traditional CHNRI
criteria were not applicable to the research priorities their team
generated; thus, this team revised some of the criteria to be more
applicable to their research priorities (Table S18 of Supporting
Information S1).
(iii) External Stakeholders Agree on Weighting
Because we needed to identify a balanced portfolio of research
and we lacked an empiric basis to weigh various aspects
objectively, we chose to weigh all CHNRI criteria equally. This
decision differs from previous CHNRI exercises where such an
approach was not used [24,25]. It was anticipated, however, that
the final ranking and hierarchy of questions would reflect the
priority listing of questions irrespective of individual ranking by the
groups themselves.
(iv) Research Scores Calculated for Each Team
The research priority score (RPS) and average expert agreement
(AEA) were used to generate a ranking of research priorities. The
RPS was computed as a mean of the scores given, by all global
experts and across all criteria scored, to a particular question. The
AEA score was calculated as a proportion of experts who gave the
most common answer for a particular research question.
We have used an AEA to display agreement rather than a
Kappa statistic, as the large number of scorers and few possible
scoring options make it impossible to rule out chance, even with
complete agreement among experts.
The AEA was computed using the following formula:
AEA~
1
15
|
X15
q~1
N scorers who provided the most frequent responseð Þ
N scorersð Þ ,
where q is a question that experts are being asked to evaluate
competing research investment options, ranging from 1 to 15.
Results
RPSs from the 466 questions (Table S15 of Supporting
Information S1) ranged from 95.63 to 36.95 with a median of
68.50. The AEA scores ranged from 0.94 to 0.40, with a median of
0.56. The top ten questions from each team are shown in Tables
S1–S10 of Supporting Information S1. The distribution of
research questions into the D4 categories can be found in
Figure 1. The top 20 research questions in the four categories
are located in Tables S11–S14 of Supporting Information S1. The
top 20 research questions overall are displayed in Table 1.
ORS/ORT and Zinc
Across the ten teams, many research questions addressed
various aspects of ORS or oral rehydration therapy (ORT), many
of which were also connected to zinc. The top five research
questions overall were related to ORS or ORT, and had RPSs
over 90.00. Of the top 50 research questions overall, 20 concerned
some aspect of ORS or ORT, many of which addressed ORS/
ORT and zinc concurrently. Of these 20, 13 related to some
feature of delivery of ORS and ORT, such as barriers to use,
Figure 1. Ten ‘‘teams’’ of research focus and distribution of research questions into Description, Discovery, Development, and
Delivery areas.
doi:10.1371/journal.pmed.1001446.g001
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driving care-seeking behaviour, and characteristics of mothers that
are associated with high use of ORS/ORT. Three of the top 50
research questions concerned improving the formulation of ORS
and two of the top 50 research questions concerned monitoring
ORS use.
Delivery Strategies
Questions relating to delivery strategies were found in three of
four D4 categories. Research questions regarding descriptions of
barriers to appropriate ORS use and attributes of successful
programs ranked highly in the Description category. Questions
regarding how to improve the uptake of the UNICEF/WHO’s
seven-point plan and the effect of low-cost, sustainable education
packages were ranked highly in the Development category.
Twenty-six of the top 50 research questions overall were either
in the Delivery category, related to further developing a delivery
strategy, or were of a descriptive nature that would inform a
delivery strategy.
Behaviour Change
There were numerous highly ranked questions regarding
behaviour changes in mothers and other caregivers. Many
research questions focused on driving care-seeking behaviour
and moving caregivers from awareness to action in general and for
specific interventions, including zinc, ORS, and hand washing
with soap. Other behaviour change–related research priorities
focused on interventions to support mothers, to encourage
responsive care/parenting, or on the effect of women’s peer
groups and counselling on childhood diarrhoeal outcomes. Of the
top 50 research questions overall, 23 involved understanding how
to change the behaviour of caregivers.
Observations on Specific Teams and D4 Categories
The Disease Burden, Aetiology and Distribution team priori-
tized developing a clear understanding of the prevalence and
distribution and risk factors of diarrhoea globally. Understanding
long-term child development outcomes was a priority in the
Nutrition and Long-Term Outcomes team, which emphasized a
need for education for diarrhoea prevention and in promoting
child development.
The Preventive Nutrition Strategies team highlighted the
importance of community involvement and education regarding
the relationship between ideal nutrition strategies and prevention
of diarrhoea. The Emerging Interventions team also prioritised
research questions regarding the importance of nutritional factors
in diarrhoeal disease.
The Diagnostics team prioritised research questions involving
availability of technology both in diagnostic labs and in the field
for accurate diagnosis of the causative agents in diarrhoea. The
Vaccines for Diarrhoea Prevention team prioritized understanding
barriers to effectiveness of oral vaccines in developing countries so
as to develop oral vaccines with improved efficacy, and
development and implementation of vaccines.
Both the Case Management team and the Monitoring and
Evaluation team emphasized research priorities around ORS and
zinc use, including determinants of use, factors that drive care-
seeking behaviour, delivery strategies, and social marketing. The
Monitoring and Evaluation team also prioritized finding factors
that have led to decline in ORS use as well as defining attributes of
successful and sustainable childhood diarrhoea programs.
In addition to placing an emphasis on ORS and zinc, the Other
Innovations team’s highly ranked questions included research
questions involving feeding practices during diarrhoea and
research questions regarding hand washing and sanitation. The
WASH Interventions team also prioritized hand washing,
highlighting the importance of better understanding the relative
contribution of different transmission routes to disease burden.
The team identified a need to study the effectiveness of programs
to improve sanitation, water supply and hygiene behaviour in the
home and in schools, and to better understand the transmission
routes of diarrhoea pathogens through the environment.
Research questions in the category of Discovery tended to rank
lower than those in Description, Development, and Delivery. The
highest-ranked research question in the area of Discovery was
twenty-third overall; the second highest Discovery question was
sixty-fifth overall. Furthermore, research questions in the Diag-
nostics and the Vaccines for Diarrhoea Prevention areas ranked
much lower relative to the research questions generated by other
teams.
Discussion
This is the largest exercise to date using the CHNRI methods
and a range of subject experts building on previous exercises to
develop priorities for diarrhoeal disease research. The latter
utilized a more limited set of experts and specifically focused on
diarrhoea mortality and morbidity in the relatively short time
frame of the MDGs [4,23]. The results of this multidisciplinary
exercise emphasize strengthening the use of ORS and ORT,
through new formulations, better delivery systems, and an
improved understanding of the barriers to appropriate use.
Research questions regarding various aspects of delivery strategies,
in general, ranked highly, as did research questions regarding
behaviour change. Research questions concerning new interven-
tions ranked relatively low, which mirrors the results of the
exercises conducted by Fontaine et al. and Kosek et al. [4,23].
Fontaine and colleagues propose that the relatively low ranking of
discovery-related questions was likely due to the short time frame
that participants were instructed to consider [4]. However, since
the time frame considered in the current exercise is one-third
greater than that considered in the 2009 exercise, an alternative
explanation for the low ranking of Discovery questions may be the
certainty of results. As Discovery questions focused on developing
entirely new interventions, research questions in Description,
Development, and Delivery may have more predictable results
than the Discovery research questions.
The current CHNRI exercise expanded the time lines of the
previous exercise to set research priorities in childhood diarrhoeal
disease over the next 15 years [4]. Fontaine et al. [4] argue that
lack of implementation and coverage of cost-effective interven-
tions, particularly in low-income settings, is a central reason that
progress in preventing childhood diarrhoeal morbidity and
mortality has stalled. The plentiful amount of high-priority
research questions focusing on delivery of interventions supports
this contention.
This CHNRI exercise differed from previous exercises by
creating ten separate teams, representing different areas within the
topic of diarrhoeal disease, that generated and ranked their own
sets of research questions. This approach ensured a wide variety of
research questions within each discipline, representation from
each discipline, and experts specific to each discipline generating
and ranking research questions. However, there were also
disadvantages to this approach. As investments in a specific
intervention can relate to multiple disciplines, there were many
duplicate questions across the ten teams. Furthermore, the
approach to creating research questions differed across teams;
for example, research questions from the Vaccines team were
much more detailed than research questions from other teams.
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The different styles of composing research questions could affect
the scores given to those questions. Moreover, the use of multiple
coordinators, some of whom had more familiarity with the
CHNRI method than others, made standardization between
teams challenging. Although each team was given the same format
to record scores, research questions from some teams seemed to
score lower as a whole than research questions from others. The
research questions from the Monitoring and Evaluation team, for
which custom CHNRI criteria were created (as described above),
scored notably higher than research questions from other teams
and 12 of the top 20 Delivery questions came from this team.
Research questions from the Vaccines, Diagnostics, WASH
Interventions, and Preventive Nutrition Strategies had relatively
lower scores. This difference could be attributable to the research
questions themselves being less important and impactful than
research questions from other teams, or it could be a result of the
experts being more critical scorers.
Although we strove to achieve global representation through
our ‘‘global experts,’’ we were unable to achieve equal represen-
tation from all regions across all areas of D4. This could bias the
types of research questions generated. In addition, questions more
relevant regions that were more heavily represented through
expert participation could have received higher scores as a result of
this potential bias.
Conclusions
While there is an unprecedented amount of investment in health
research [10,32], vast inequities exist in the conditions being
funded. MDG 4 seeks to reduce global childhood mortality by
two-thirds by 2015. Despite proven cost-effective interventions,
diarrhoeal disease remains the second most important cause of
death in children under five [6].
This exercise represents an important effort to assist policy-
makers in identifying research gaps and resource priorities in
childhood global diarrhoeal disease. Results of this CHNRI
exercise emphasize a need for research to improve delivery and
implementation of existing interventions.
The research priorities of this CHNRI exercise and the previous
CHNRI exercise addressing childhood pneumonia [25] will be
incorporated into the integrated GAPPD and will be shared with
funders, donors, and science bodies over the next 24 months. The
GAPPD will include contributions from key stakeholders, such as
WHO, UNICEF, and USAID. Relevant stakeholders and UN
agencies in six pilot countries in South Asia and East Africa have
agreed to implement the GAPPD. Further development and
implementation of GAPPD is planned for South Asia and East
Africa.
Reducing the diarrheal morbidity and mortality in low- and
middle-income countries to the levels of that in high-income
countries is within our grasp. Combined efforts from all
stakeholders, including donors and bilateral agencies, as well as
country-level commitments and strong political will, are necessary
to achieve this goal through effective implementation of currently
available interventions.
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